Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Stability Biologics

Stability Biologics
2010 FOUNDED
M&A STATUS
21-30 EMPLOYEES
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Developer of bioactive bone graft products and tissue allografts. The company's bioactive bone graft products and tissue allografts include structural or particulate bone, structural allografts, demineralized bone matrix (DBM), skin products for burns and traumatic wound care and bone grafting materials, enabling physicians, hospitals and surgery centers in United States to quickyl and effectively complete safe surgical procedures on patients.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Distributors (Healthcare)
Primary Office
  • 2910 Poston Avenue
  • Nashville, TN 37203
  • United States

+1 (855) 000-0000

Stability Biologics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Stability Biologics‘s full profile, request access.

Request full access to PitchBook

Stability Biologics Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Stability Biologics‘s full profile, request access.

Request full access to PitchBook

Stability Biologics Executive Team (3)

Name Title Board
Seat
Contact
Info
Brian Martin Chief Executive Officer and Co-Founder
Tom Johnston President and Co-Founder
Erik Erbe Ph.D Chief Science Officer